Fingerprint
Dive into the research topics of 'Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) – A phase III study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ertugliflozin to reduce arrhythmic burden in ICD/CRT patients (ERASe-trial) – A phase III study
ERASe study group
Research output: Contribution to journal › Article › peer-review
2
Citations
(Scopus)